Perifériás B-lymphocyták markerei és funkciója IgA-nephropathiában.

Translated title of the contribution: Markers of peripheral B lymphocytes and their function in IgA nephropathy

T. Magyarlaki, J. Nagy, E. Szabados, A. Pár, B. Kocsis

Research output: Contribution to journalArticle

Abstract

Peripheral blood B-lymphocyte markers and functions were observed in 21 patients with IgA nephropathy (IgA NP), 18 patients with systemic lupus erythematosus (SLE) and 16 controls. IgA NP B-lymphocytes similarly to that of SLE B-lymphocytes expressed significantly higher positivity with Leu 1 (CD 5) monoclonal antibody than controls. CD 5 positive B-lymphocytes are thought to be a distinct subset of the B-cells (autoregulatory B-lymphocytes) inducible in IgA NP by lipopolysaccharide (LPS) stimulation in parallel to their expression of surface IgM heavy chain positivity. The activated state of IgA NP B-lymphocytes have been proved by their higher OKIa (HLA-DR) positivities but lower IOB1a (CD 21, C3b-receptor) and decreased IgG-Fc-receptor (ox- rosette) expression. IgA NP B-lymphocytes showed a higher IgA but also IgG and IgM polyclonal immunoglobulin production than control B-lymphocytes in co-cultures with T-lymphocytes. Not only regulatory T-lymphocyte subsets but also serum derived from IgA NP patients stimulated the immunoglobulin production of IgA NP B-lymphocytes.

Original languageHungarian
Pages (from-to)1623-1627
Number of pages5
JournalOrvosi Hetilap
Volume131
Issue number30
Publication statusPublished - Jul 29 1990

Fingerprint

Immunoglobulin A
B-Lymphocytes
Systemic Lupus Erythematosus
Immunoglobulin M
Immunoglobulins
Complement 3b Receptors
B-Lymphocyte Subsets
IgG Receptors
Fc Receptors
T-Lymphocyte Subsets
HLA-DR Antigens
Regulatory T-Lymphocytes
Coculture Techniques
Lipopolysaccharides
Immunoglobulin G
Monoclonal Antibodies
T-Lymphocytes
Serum

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Perifériás B-lymphocyták markerei és funkciója IgA-nephropathiában. / Magyarlaki, T.; Nagy, J.; Szabados, E.; Pár, A.; Kocsis, B.

In: Orvosi Hetilap, Vol. 131, No. 30, 29.07.1990, p. 1623-1627.

Research output: Contribution to journalArticle

@article{978262b7ca4a470c97db4fb284434a86,
title = "Perif{\'e}ri{\'a}s B-lymphocyt{\'a}k markerei {\'e}s funkci{\'o}ja IgA-nephropathi{\'a}ban.",
abstract = "Peripheral blood B-lymphocyte markers and functions were observed in 21 patients with IgA nephropathy (IgA NP), 18 patients with systemic lupus erythematosus (SLE) and 16 controls. IgA NP B-lymphocytes similarly to that of SLE B-lymphocytes expressed significantly higher positivity with Leu 1 (CD 5) monoclonal antibody than controls. CD 5 positive B-lymphocytes are thought to be a distinct subset of the B-cells (autoregulatory B-lymphocytes) inducible in IgA NP by lipopolysaccharide (LPS) stimulation in parallel to their expression of surface IgM heavy chain positivity. The activated state of IgA NP B-lymphocytes have been proved by their higher OKIa (HLA-DR) positivities but lower IOB1a (CD 21, C3b-receptor) and decreased IgG-Fc-receptor (ox- rosette) expression. IgA NP B-lymphocytes showed a higher IgA but also IgG and IgM polyclonal immunoglobulin production than control B-lymphocytes in co-cultures with T-lymphocytes. Not only regulatory T-lymphocyte subsets but also serum derived from IgA NP patients stimulated the immunoglobulin production of IgA NP B-lymphocytes.",
author = "T. Magyarlaki and J. Nagy and E. Szabados and A. P{\'a}r and B. Kocsis",
year = "1990",
month = "7",
day = "29",
language = "Hungarian",
volume = "131",
pages = "1623--1627",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "30",

}

TY - JOUR

T1 - Perifériás B-lymphocyták markerei és funkciója IgA-nephropathiában.

AU - Magyarlaki, T.

AU - Nagy, J.

AU - Szabados, E.

AU - Pár, A.

AU - Kocsis, B.

PY - 1990/7/29

Y1 - 1990/7/29

N2 - Peripheral blood B-lymphocyte markers and functions were observed in 21 patients with IgA nephropathy (IgA NP), 18 patients with systemic lupus erythematosus (SLE) and 16 controls. IgA NP B-lymphocytes similarly to that of SLE B-lymphocytes expressed significantly higher positivity with Leu 1 (CD 5) monoclonal antibody than controls. CD 5 positive B-lymphocytes are thought to be a distinct subset of the B-cells (autoregulatory B-lymphocytes) inducible in IgA NP by lipopolysaccharide (LPS) stimulation in parallel to their expression of surface IgM heavy chain positivity. The activated state of IgA NP B-lymphocytes have been proved by their higher OKIa (HLA-DR) positivities but lower IOB1a (CD 21, C3b-receptor) and decreased IgG-Fc-receptor (ox- rosette) expression. IgA NP B-lymphocytes showed a higher IgA but also IgG and IgM polyclonal immunoglobulin production than control B-lymphocytes in co-cultures with T-lymphocytes. Not only regulatory T-lymphocyte subsets but also serum derived from IgA NP patients stimulated the immunoglobulin production of IgA NP B-lymphocytes.

AB - Peripheral blood B-lymphocyte markers and functions were observed in 21 patients with IgA nephropathy (IgA NP), 18 patients with systemic lupus erythematosus (SLE) and 16 controls. IgA NP B-lymphocytes similarly to that of SLE B-lymphocytes expressed significantly higher positivity with Leu 1 (CD 5) monoclonal antibody than controls. CD 5 positive B-lymphocytes are thought to be a distinct subset of the B-cells (autoregulatory B-lymphocytes) inducible in IgA NP by lipopolysaccharide (LPS) stimulation in parallel to their expression of surface IgM heavy chain positivity. The activated state of IgA NP B-lymphocytes have been proved by their higher OKIa (HLA-DR) positivities but lower IOB1a (CD 21, C3b-receptor) and decreased IgG-Fc-receptor (ox- rosette) expression. IgA NP B-lymphocytes showed a higher IgA but also IgG and IgM polyclonal immunoglobulin production than control B-lymphocytes in co-cultures with T-lymphocytes. Not only regulatory T-lymphocyte subsets but also serum derived from IgA NP patients stimulated the immunoglobulin production of IgA NP B-lymphocytes.

UR - http://www.scopus.com/inward/record.url?scp=0025716005&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025716005&partnerID=8YFLogxK

M3 - Article

VL - 131

SP - 1623

EP - 1627

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 30

ER -